QQQ   353.15 (+1.24%)
AAPL   180.57 (+1.55%)
MSFT   325.26 (+0.58%)
META   264.58 (+0.37%)
GOOGL   122.14 (-0.29%)
AMZN   124.25 (+2.49%)
TSLA   234.86 (+4.58%)
NVDA   385.10 (+2.76%)
NIO   7.79 (+0.39%)
BABA   86.14 (+1.01%)
AMD   121.05 (+2.73%)
T   16.07 (-0.25%)
F   13.58 (-0.07%)
MU   65.32 (-2.59%)
CGC   0.69 (-4.14%)
GE   106.06 (-0.02%)
DIS   92.53 (+0.01%)
AMC   4.68 (-1.06%)
PFE   39.09 (+0.51%)
PYPL   64.24 (+0.31%)
NFLX   409.37 (+2.40%)
QQQ   353.15 (+1.24%)
AAPL   180.57 (+1.55%)
MSFT   325.26 (+0.58%)
META   264.58 (+0.37%)
GOOGL   122.14 (-0.29%)
AMZN   124.25 (+2.49%)
TSLA   234.86 (+4.58%)
NVDA   385.10 (+2.76%)
NIO   7.79 (+0.39%)
BABA   86.14 (+1.01%)
AMD   121.05 (+2.73%)
T   16.07 (-0.25%)
F   13.58 (-0.07%)
MU   65.32 (-2.59%)
CGC   0.69 (-4.14%)
GE   106.06 (-0.02%)
DIS   92.53 (+0.01%)
AMC   4.68 (-1.06%)
PFE   39.09 (+0.51%)
PYPL   64.24 (+0.31%)
NFLX   409.37 (+2.40%)
QQQ   353.15 (+1.24%)
AAPL   180.57 (+1.55%)
MSFT   325.26 (+0.58%)
META   264.58 (+0.37%)
GOOGL   122.14 (-0.29%)
AMZN   124.25 (+2.49%)
TSLA   234.86 (+4.58%)
NVDA   385.10 (+2.76%)
NIO   7.79 (+0.39%)
BABA   86.14 (+1.01%)
AMD   121.05 (+2.73%)
T   16.07 (-0.25%)
F   13.58 (-0.07%)
MU   65.32 (-2.59%)
CGC   0.69 (-4.14%)
GE   106.06 (-0.02%)
DIS   92.53 (+0.01%)
AMC   4.68 (-1.06%)
PFE   39.09 (+0.51%)
PYPL   64.24 (+0.31%)
NFLX   409.37 (+2.40%)
QQQ   353.15 (+1.24%)
AAPL   180.57 (+1.55%)
MSFT   325.26 (+0.58%)
META   264.58 (+0.37%)
GOOGL   122.14 (-0.29%)
AMZN   124.25 (+2.49%)
TSLA   234.86 (+4.58%)
NVDA   385.10 (+2.76%)
NIO   7.79 (+0.39%)
BABA   86.14 (+1.01%)
AMD   121.05 (+2.73%)
T   16.07 (-0.25%)
F   13.58 (-0.07%)
MU   65.32 (-2.59%)
CGC   0.69 (-4.14%)
GE   106.06 (-0.02%)
DIS   92.53 (+0.01%)
AMC   4.68 (-1.06%)
PFE   39.09 (+0.51%)
PYPL   64.24 (+0.31%)
NFLX   409.37 (+2.40%)
NYSE:CBT

Cabot (CBT) Stock Forecast, Price & News

$74.68
-1.06 (-1.40%)
(As of 06/8/2023 ET)
Compare
Today's Range
$73.69
$75.98
50-Day Range
$68.10
$76.74
52-Week Range
$59.65
$83.74
Volume
179,585 shs
Average Volume
297,346 shs
Market Capitalization
$4.19 billion
P/E Ratio
13.46
Dividend Yield
2.14%
Price Target
$91.75

Cabot MarketRank™ Forecast

Analyst Rating
Moderate Buy
2.75 Rating Score
Upside/​Downside
22.9% Upside
$91.75 Price Target
Short Interest
Healthy
1.75% of Float Sold Short
Dividend Strength
Moderate
Based on Four Factors
Sustainability
-4.25
Upright™ Environmental Score
News Sentiment
-0.05mentions of Cabot in the last 14 days
Based on 9 Articles This Week
Insider Trading
N/A
Proj. Earnings Growth
N/A

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

1.84 out of 5 stars

Basic Materials Sector

125th out of 164 stocks

Miscellaneous Chemical Products Industry

4th out of 5 stocks


CBT stock logo

About Cabot (NYSE:CBT) Stock

Cabot Corp. is a global specialty chemicals and performance materials company. Its products are rubber and specialty grade carbon blacks, specialty compounds, fumed metal oxides, activated carbons, inkjet colorants, and aerogel. The company operates through the following segments: Reinforcement Materials, Performance Chemicals, and Purification Solutions. The Reinforcement Materials segment involves the rubber blacks and elastomer composites product lines. The Performance Chemicals segment combines the specialty carbons and compounds and inkjet colorants product lines into the specialty carbons and formulations business. The Purification Solutions segment refers to the activated carbon business and the specialty fluids segment. The company was founded by Godfrey Lowell Cabot in 1882 and is headquartered in Boston, MA.

Receive CBT Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Cabot and its competitors with MarketBeat's FREE daily newsletter.

CBT Stock News Headlines

BREAKING: Tiny biotech successfully treats blindness
There's a tiny biotech in Cambridge that's using a breakthrough technology to treat blindness. This company has already shown success in human trials... And Our research shows that anyone who gets in today could see a 46,751% return.
Expert Ratings for Cabot
JP Morgan Downgrades Cabot (CBT)
AI Creates New Cancer Drug - In Just 30 Days!
On December 22, 2022, AI discovered a new treatment for multiple myeloma... in just 4 months... On March 19, 2023, AI discovered a new drug for liver cancer... in only 30 days... There's one small-cap at the center of it all. Bill Gates owns 7 million shares... Billionaire hedge-fund manager Steve Cohen owns 1.4 million shares...
Cabot Co. (NYSE:CBT) Plans Quarterly Dividend of $0.40
Cabot (NYSE:CBT) Research Coverage Started at StockNews.com
How To Trade Cabot $CBT
Where Cabot Stands With Analysts
Cabot Corporation Board Increases Dividend
Cabot (CBT) to Release Quarterly Earnings on Monday
Cabot Stock (NYSE:CBT), Short Interest Report
See More Headlines

CBT Price History

CBT Company Calendar

Ex-Dividend for 3/10 Dividend
2/23/2023
Dividend Payable
3/10/2023
Last Earnings
5/08/2023
Ex-Dividend for 6/9 Dividend
5/25/2023
Today
6/08/2023
Dividend Payable
6/09/2023
Next Earnings (Estimated)
8/14/2023
Fiscal Year End
9/30/2023

Industry, Sector and Symbol

Industry
Miscellaneous chemical products
Sub-Industry
Commodity Chemicals
CUSIP
12705510
Employees
4,200
Year Founded
1882

Price Target and Rating

Average Stock Price Forecast
$91.75
High Stock Price Forecast
$113.00
Low Stock Price Forecast
$80.00
Forecasted Upside/Downside
+23.7%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.75
Research Coverage
4 Analysts

Profitability

Net Income
$209 million
Pretax Margin
11.15%

Debt

Sales & Book Value

Annual Sales
$4.32 billion
Cash Flow
$9.05 per share
Book Value
$18.33 per share

Miscellaneous

Free Float
54,630,000
Market Cap
$4.17 billion
Optionable
Optionable
Beta
1.33

Social Links


Key Executives

  • Sean D. KeohaneSean D. Keohane
    President, Chief Executive Officer & Director
  • Erica J. McLaughlin
    Chief Financial Officer & Executive Vice President
  • Patricia Hubbard
    Chief Technology Officer & Senior Vice President
  • Hobart C. KalksteinHobart C. Kalkstein
    EVP & President-Reinforcement Materials Segment
  • Jeff Zhu
    Executive VP & President-Asia Pacific Region













CBT Stock - Frequently Asked Questions

Should I buy or sell Cabot stock right now?

4 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Cabot in the last twelve months. There are currently 1 hold rating and 3 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" CBT shares.
View CBT analyst ratings
or view top-rated stocks.

What is Cabot's stock price forecast for 2023?

4 equities research analysts have issued 12 month target prices for Cabot's stock. Their CBT share price forecasts range from $80.00 to $113.00. On average, they anticipate the company's stock price to reach $91.75 in the next year. This suggests a possible upside of 23.7% from the stock's current price.
View analysts price targets for CBT
or view top-rated stocks among Wall Street analysts.

How have CBT shares performed in 2023?

Cabot's stock was trading at $66.84 at the beginning of 2023. Since then, CBT shares have increased by 11.0% and is now trading at $74.19.
View the best growth stocks for 2023 here
.

Are investors shorting Cabot?

Cabot saw a increase in short interest during the month of May. As of May 15th, there was short interest totaling 967,400 shares, an increase of 10.5% from the April 30th total of 875,500 shares. Based on an average daily volume of 286,100 shares, the days-to-cover ratio is presently 3.4 days. Currently, 1.8% of the shares of the company are short sold.
View Cabot's Short Interest
.

When is Cabot's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Monday, August 14th 2023.
View our CBT earnings forecast
.

How were Cabot's earnings last quarter?

Cabot Co. (NYSE:CBT) announced its quarterly earnings results on Monday, May, 8th. The specialty chemicals company reported $1.33 EPS for the quarter, meeting analysts' consensus estimates of $1.33. The specialty chemicals company earned $1.03 billion during the quarter, compared to analyst estimates of $1.11 billion. Cabot had a net margin of 7.51% and a trailing twelve-month return on equity of 28.94%. The firm's revenue was down 5.4% compared to the same quarter last year. During the same period in the prior year, the firm earned $1.69 EPS.

How often does Cabot pay dividends? What is the dividend yield for Cabot?

Cabot declared a quarterly dividend on Friday, May 5th. Shareholders of record on Friday, May 26th will be given a dividend of $0.40 per share on Friday, June 9th. This represents a $1.60 dividend on an annualized basis and a yield of 2.16%. The ex-dividend date is Thursday, May 25th. This is a positive change from the stock's previous quarterly dividend of $0.37.
Read our dividend analysis for CBT
.

Is Cabot a good dividend stock?

Cabot (NYSE:CBT) pays an annual dividend of $1.60 per share and currently has a dividend yield of 2.17%. The company does not yet have a strong track record of dividend growth. The dividend payout ratio is 28.83%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, CBT will have a dividend payout ratio of 25.24% next year. This indicates that the company will be able to sustain or increase its dividend.
Read our dividend analysis for CBT.

What guidance has Cabot issued on next quarter's earnings?

Cabot updated its FY23 earnings guidance on Monday, May, 8th. The company provided EPS guidance of $6.10-$6.50 for the period, compared to the consensus earnings per share estimate of $6.45.

What is Sean Keohane's approval rating as Cabot's CEO?

40 employees have rated Cabot Chief Executive Officer Sean Keohane on Glassdoor.com. Sean Keohane has an approval rating of 96% among the company's employees. This puts Sean Keohane in the top 30% of approval ratings compared to other CEOs of publicly-traded companies.

What other stocks do shareholders of Cabot own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Cabot investors own include Pfizer (PFE), Broadcom (AVGO), Energy Transfer (ET), AT&T (T), Gilead Sciences (GILD), Intel (INTC), NVIDIA (NVDA), Advanced Micro Devices (AMD), Cisco Systems (CSCO) and Coca-Cola (KO).

What is Cabot's stock symbol?

Cabot trades on the New York Stock Exchange (NYSE) under the ticker symbol "CBT."

Who are Cabot's major shareholders?

Cabot's stock is owned by a number of institutional and retail investors. Top institutional shareholders include BlackRock Inc. (11.64%), FMR LLC (8.34%), Wellington Management Group LLP (8.22%), State Street Corp (3.40%), Snyder Capital Management L P (3.13%) and Bank of America Corp DE (2.53%). Insiders that own company stock include Hobart Kalkstein, Karen A Kalita, Karen A Kalita and Sean D Keohane.
View institutional ownership trends
.

How do I buy shares of Cabot?

Shares of CBT stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Cabot's stock price today?

One share of CBT stock can currently be purchased for approximately $74.19.

How much money does Cabot make?

Cabot (NYSE:CBT) has a market capitalization of $4.17 billion and generates $4.32 billion in revenue each year. The specialty chemicals company earns $209 million in net income (profit) each year or $5.55 on an earnings per share basis.

How many employees does Cabot have?

The company employs 4,200 workers across the globe.

Does Cabot have any subsidiaries?
The following companies are subsidiares of Cabot: 8755329 Canada Inc., AHB Investments Limited, AP Materials, Aizu Holdings G.K., Altamira Carbon S.A. de C.V., Anglo Dutch Water Carbons Limited, Applied NanoStructured Solutions LLC, BCB Company, Beyond Lotus LLC, Black Rose Investments Limited, Botsel Limited, CDE Company, CMHC Inc., CS Cabot spol s.r.o., Cabot (Bermuda) Ltd., Cabot (China) Limited, Cabot (Malaysia) Sdn. Bhd., Cabot Activated Carbon B.V., Cabot Activated Carbon Holdings UK Limited, Cabot Activated Carbon LLC, Cabot Activated Carbon UK Limited, Cabot Aerogel GmbH, Cabot Argentina S.A.I.C., Cabot Asia Investments Corporation, Cabot Asia Kumiai, Cabot Asia Sdn. Bhd., Cabot B.V., Cabot Bluestar Chemical (Jiangxi) Co. Ltd., Cabot Brasil Industria e Comércio Ltda., Cabot CSC LLC, Cabot Canada Ltd., Cabot Carbon Limited, Cabot Carbone S.A.S., Cabot Ceramics Inc., Cabot Chemical (Tianjin) Co. Ltd., Cabot Colombiana S.A., Cabot Corporation Foundation Inc., Cabot Czech Holding Company s.r.o., Cabot Europe Limited, Cabot Finance B.V., Cabot France S.A.S., Cabot G.B. Limited, Cabot Germany, Cabot HengYeCheng Performance Materials (Inner-Mongolia) Company Limited, Cabot Holdings I GmbH, Cabot Holdings II GmbH, Cabot Holdings LLC, Cabot India Limited, Cabot Insurance Co. Ltd. (Vermont), Cabot International Capital Corporation, Cabot International GmbH, Cabot International Limited, Cabot International Services Corporation, Cabot Italiana S.p.A., Cabot Japan K.K., Cabot Korea Y.H., Cabot Luxembourg Holdings S.a.r.l., Cabot Luxembourg Investments S.a.r.l., Cabot Luxembourg TC S.a.r.l., Cabot Materials Research Sdn Bhd., Cabot NHUMO Holding S.A.P.I. de C.V., Cabot NHUMO Holdings I S.a.r.l., Cabot Norit (UK) Limited, Cabot Norit Americas Inc., Cabot Norit Canada Inc., Cabot Norit Italia S.p.A., Cabot Norit Japan Co. Ltd., Cabot Norit Nederland B.V., Cabot Norit Singapore Pte. Ltd., Cabot Norit Technology B.V., Cabot Performance Materials (Shenzhen) Co. Ltd., Cabot Performance Materials (Xuzhou) Co. Ltd. (fka NSCC Carbon (Jiangsu) Co. Ltd.), Cabot Performance Materials (Zhuhai) Co. Ltd., Cabot Performance Materials Belgium S.P.R.L., Cabot Performance Materials Italy S.r.l, Cabot Performance Materials Netherlands B.V., Cabot Performance Materials UK Limited, Cabot Performance Products (Tianjin) Co. Ltd., Cabot Performance Products FZE, Cabot Plastics Belgium S.A., Cabot Plastics Canada LP, Cabot Plastics Hong Kong Limited, Cabot Plastics Limited, Cabot Risun Chemical (Xingtai) Co. Ltd., Cabot S.A., Cabot Singapore Pte. Ltd., Cabot Specialty Chemicals Inc., Cabot Specialty Chemicals Mexico S.A.P.I. de C.V., Cabot Specialty Fluids North Sea Limited, Cabot Supermetals K.K., Cabot Switzerland GmbH, Cabot Trading (Shanghai) Company Ltd., Cabot Turkey Performans Malzemeleri Anonim Şirketi, Cabot U.K. Limited, Cabot UK Holdings II Limited, Cabot UK Holdings III Limited, Cabot UK Holdings Limited, Dragón Verde Investments Limited, Eco-Cabot Activated Carbon Ptd. Ltd., Energy Transport Limited LLC, HDF Investments Limited, Kawecki Chemicals Inc., Mexico Reinforcement Materials S.A.P.I. de C.V., N.V. Norit Belgium, Norit (UK) Holding Limited, Norit Americas Holding Inc., Norit China Limited, Norit EAPA Holding B.V., Norit Holding B.V., Norit International B.V., Norit N.V., Norit Real Estate B.V., Northeast Boulevard LLC, Oxonica, P.T. Cabot Indonesia, PT Cabot Asia Pacific South, Purton Carbons Limited, Ramaai Holdings Limited, Representaciones 1 2 y 3 C.A., SIA Cabot Latvia, Shanghai Cabot Chemical Company Ltd., Shenzhen Sanshun Nano New Materials Co. Ltd, Superior MicroPowders, Tech Blend, Tech Blend Corp., and Valores Ramaai C.A..
Read More
How can I contact Cabot?

Cabot's mailing address is TWO SEAPORT LANE SUITE 1300, BOSTON MA, 02210. The official website for the company is www.cabot-corp.com. The specialty chemicals company can be reached via phone at (617) 345-0100, via email at steve.delahunt@cabotcorp.com, or via fax at 617-342-6103.

This page (NYSE:CBT) was last updated on 6/8/2023 by MarketBeat.com Staff

My Account -